Pre-Open Movers

DBV Technologies (Nasdaq: DBVT) 50.7% LOWER; announced that the U.S. Food and Drug Administration (FDA) has informed the Company that during its ongoing review of the Biologics License Application (BLA) for investigational Viaskin Peanut, it has identified questions regarding efficacy, including the impact of patch-site adhesion. Therefore, the Allergenic Products Advisory Committee (APAC) meeting to discuss the BLA will no longer take place as previously scheduled on May 15, 2020.

BioNTech SE (NASDAQ: BNTX) 54% HIGHER; the company and Pfizer (NYSE: PFE) entered into a co-development and distribution (excluding China) of a potential mRNA-based coronavirus vaccine aimed at preventing COVID-19 infection.

Co-Diagnostics, Inc. (NASDAQ: CODX) 41.5% HIGHER; coronavirus stocks gain

GNC Holdings, Inc. (NYSE: GNC) 40% LOWER; GNC Doesn’t Expect to Have Cash to Pay Notes, Loan When Due

Blue Apron (NYSE: APRN) 36.4% HIGHER; food delivery service could see increased demand amid home quarantines.

Fulgent Genetics, Inc. (NASDAQ: FLGT) 31% HIGHER; announced the launch of a Next Generation Sequencing based test for the Coronavirus Disease (COVID-19). Fulgents NGS test will be one of the markets first diagnostic tests for the COVID-19 virus developed based on NGS technology. Fulgent and MedScan will begin accepting specimens for testing this week from healthcare providers, clinics and reference labs.

Mallinckrodt plc (NYSE: MNK) 11% HIGHER; announced the completion of its rolling submission of a New Drug Application (NDA) to the U.S. Food and Drug Administration (FDA) for terlipressin, an investigational agent being evaluated for the treatment of hepatorenal syndrome type 1 (HRS-1). The company previously announced the rolling submission, which it initiated in February.

Moderna, Inc. (NASDAQ: MRNA) 9.3% HIGHER; adds to intra-day after dosing first patients in COVID-19 vaccine trial

HealthEquity (NASDAQ: HQY) 7% LOWER; reported Q4 EPS of $0.39, $0.04 better than the analyst estimate of $0.35. Revenue for the quarter came in at $201.2 versus the consensus estimate of $199.26 million. HealthEquity sees FY2021 EPS of $1.70-$1.81, versus the consensus of $1.80. HealthEquity sees FY2021 revenue of $770-790 million, versus the consensus of $821.5 million.

Caesars Entertainment (NYSE: CZR) 6.7% HIGHER; has fully drawn the remaining available capacity under each of the Revolving Credit Facilities

Roku (NASDAQ: ROKU) 6.5% LOWER; Block Trade is Said to Offer 6M Shares at $57.50 to $59.00 - Bloomberg

Chesapeake Energy (NYSE: CHK) 6% LOWER; taps debt restructuring advisers - Reuters

Norwegian Cruise Line (NYSE: NCLH) 4.7% HIGHER; Draws Down Entire $1.55B Credit Facility

Coupa Software (NASDAQ: COUP) 2.7% HIGHER; reported Q4 EPS of $0.21, $0.16 better than the analyst estimate of $0.05. Revenue for the quarter came in at $111.5 million versus the consensus estimate of $102.44 million. Coupa Software sees Q1 2021 EPS of $0.06-$0.08, versus the consensus of $0.07. Coupa Software sees Q1 2021 revenue of $111.5-112.5 million, versus the consensus of $106.8 million. Coupa Software sees FY2021 EPS of $0.30-$0.33, versus the consensus of $0.47. Coupa Software sees FY2021 revenue of $488-490 million, versus the consensus of $487.45 million.

Sprouts Farmers Market (NASDAQ: SFM) 1.5% HIGHER; Gordon Haskett upgraded from Hold to Buy.

Southwest Airlines (NYSE: LUV) 1.3% HIGHER; is withdrawing its previous 2020 financial guidance, has drawn down full $1B revolving credit facility

Zoom Video (NASDAQ: ZM) 1% HIGHER; Needham & Company initiates coverage on with a Buy rating and a price target of $140.00.

You May Also Be Interested In

• Snap (SNAP), Meta (META) gain as House orders sale or ban of TikTok
• Nutriband (NTRB) Announces 2.1M Share Offering at $4/sh
• Avalon GloboCare (ALBT) Announces Launch of U.S. Sales of KetoAir Breathalyzer